National Institute on Aging; Notice of Closed Meetings., 28513-28514 [07-2490]
Download as PDF
Federal Register / Vol. 72, No. 97 / Monday, May 21, 2007 / Notices
Time: June 29, 2007, 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Plaza, 10 Thomas Circle
NW., Washington, DC 20005.
Contact Person: William J Johnson, PhD,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7178, Bethesda, MD 20892–7924, 301–435–
0725, johnsonw@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center For
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 14, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–2489 Filed 5–18–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
pwalker on PROD1PC71 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Research on Drug Marketing and Social
Dimensions of Street Drugs.
Date: May 31, 2007.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Jurys Washington Hotel, 1500 New
Hampshire Avenue, NW., Washington, DC
200036.
Contact Person: Gerald L. McLaughin, PhD,
Scientific Review Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Blvd., Bethesda, MD
20892–8401, 301–402–6626, gm145@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
VerDate Aug<31>2005
15:57 May 18, 2007
Jkt 211001
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Extinction Learning and Pharmacotherapies
of Drug Addiction/Extinction and
Pharmacotherapies.
Date: July 2, 2007.
Time: 8:30 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington, DC 20037.
Contact Person: Rita Liu, PhD, Associate
Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, 301–
435–1388, rliu@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Centers
Review Committee.
Date: July 16, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Rita Liu, PhD, Associate
Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, 301–
435–1388, rliu@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Program
Projects.
Date: July 17, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Rita Liu, PhD, Associate
Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, 301–
435–1388, rliu@nida.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: May 14, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–2487 Filed 5–18–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
28513
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Aging Special Emphasis Panel, Koo P01
Teleconference.
Date: June 7, 2007.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Louise L Hsu, PhD, Health
Scientist Administrator, Scientific Review
Office, National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue/Suite
2C212, Bethesda, MD 20892 (301) 496–7705,
hsul@exmur.nia.nih.gov.
Name of Committee: National Institute of
Aging Special Emphasis Panel, AVV–NGF
TRIAL.
Date: June 7, 2007.
Time: 5 p.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Ramesh Vemuri, PhD,
Scientific Review Office, National Institute
on Aging, National Institutes of Health,7201
Wisconsin Avenue, Suite 2C–212, (301) 402–
7700, rv23r@nia.nih.gov.
Name of Committee: National Institute of
Aging Special Emphasis Panel, MOR P01–A2
Review.
Date: June 11, 2007.
Time: 11:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Jon E. Rolf, PhD, Scientific
Review Administrator, Scientific Review
Office, National Institute on Aging, Bethesda,
MD 20814, (301) 402–7703, rolfj@nia.nih.gov.
Name of Committee: National Institute of
Aging Special Emphasis Panel, U01 Drug
Study.
Date: June 18, 2007.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Louise L. Hsu, PhD, Health
Scientist Administrator, Scientific Review
E:\FR\FM\21MYN1.SGM
21MYN1
28514
Federal Register / Vol. 72, No. 97 / Monday, May 21, 2007 / Notices
Office, National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue/Suite
2C212, Bethesda, MD 20892, (301) 496–7705,
hsul@exmur.nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, AD Clinical
Trials.
Date: June 22, 2007.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Ramesh Vemuri, PhD,
Scientific Review Office, National Institute
on Aging, National Institutes of Health, 7201
Wisconsin Avenue, Suite 2C–212, Bethesda,
MD 20892, 301–402–7700, rv23r@nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, EXERCISE
AND DISABILITY.
Date: June 25, 2007.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Ramesh Vemuri, PhD,
Scientific Review Office, National Institute
on Aging, National Institutes of Health, 7201
Wisconsin Avenue, Suite 2C–212, Bethesda,
MD 20892, 301–402–7700, rv23r@nih.gov
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
pwalker on PROD1PC71 with NOTICES
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
15:57 May 18, 2007
Jkt 211001
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, NSDK Member Conflict
SEP.
Date: June 29, 2007.
Time: 8 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate Hotel, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Alan L. Willard, PhD,
Scientific Review Administrator, Scientific
Review Branch NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, (301) 496–5390,
willarda@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: May 14, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–2492 Filed 5–18–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Dated: May 14, 2007.
Jennifer Spaeth
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–2490 Filed 5–18–07; 8:45 am]
VerDate Aug<31>2005
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal property.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Efficacy of Setraline
as a Treatment for Cholestatic Pruritus.
Date: June 29, 2007.
Time: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Contact Person: Paul A. Rushing, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 747, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)–
594–8895, rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, The NIDDK
Digestive Disease Development Centers
Review.
Date: July 13, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Bethesda North Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Xiaodu Guo, MD, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 910, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)–
594–4719, guox@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, CRISP and AASK
Ancillary Studies.
Date: July 13, 2007.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20852, (Telephone
Conference Call).
Contact Person: Barbara A. Woynarowska,
PhD, Scientific Review Administrator,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 754, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301)–402–7172,
woynarowskab@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: May 14, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–2493 Filed 5–18–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the Developmental
Biology Subcommittee, June 7, 2007,
8:30 a.m. to June 7, 2007, 5 p.m., Hotel
Washington, Pennsylvania Avenue at
15th Street, NW., Washington, DC
E:\FR\FM\21MYN1.SGM
21MYN1
Agencies
[Federal Register Volume 72, Number 97 (Monday, May 21, 2007)]
[Notices]
[Pages 28513-28514]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-2490]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meetings.
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Aging Special Emphasis
Panel, Koo P01 Teleconference.
Date: June 7, 2007.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Louise L Hsu, PhD, Health Scientist
Administrator, Scientific Review Office, National Institute on
Aging, Gateway Building, 7201 Wisconsin Avenue/Suite 2C212,
Bethesda, MD 20892 (301) 496-7705, hsul@exmur.nia.nih.gov.
Name of Committee: National Institute of Aging Special Emphasis
Panel, AVV-NGF TRIAL.
Date: June 7, 2007.
Time: 5 p.m. to 7 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, 2C212, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Ramesh Vemuri, PhD, Scientific Review Office,
National Institute on Aging, National Institutes of Health,7201
Wisconsin Avenue, Suite 2C-212, (301) 402-7700, rv23r@nia.nih.gov.
Name of Committee: National Institute of Aging Special Emphasis
Panel, MOR P01-A2 Review.
Date: June 11, 2007.
Time: 11:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Jon E. Rolf, PhD, Scientific Review
Administrator, Scientific Review Office, National Institute on
Aging, Bethesda, MD 20814, (301) 402-7703, rolfj@nia.nih.gov.
Name of Committee: National Institute of Aging Special Emphasis
Panel, U01 Drug Study.
Date: June 18, 2007.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Louise L. Hsu, PhD, Health Scientist
Administrator, Scientific Review
[[Page 28514]]
Office, National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue/Suite 2C212, Bethesda, MD 20892, (301) 496-7705,
hsul@exmur.nia.nih.gov.
Name of Committee: National Institute on Aging Special Emphasis
Panel, AD Clinical Trials.
Date: June 22, 2007.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, 2C212, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Ramesh Vemuri, PhD, Scientific Review Office,
National Institute on Aging, National Institutes of Health, 7201
Wisconsin Avenue, Suite 2C-212, Bethesda, MD 20892, 301-402-7700,
rv23r@nih.gov.
Name of Committee: National Institute on Aging Special Emphasis
Panel, EXERCISE AND DISABILITY.
Date: June 25, 2007.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, 2C212, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Ramesh Vemuri, PhD, Scientific Review Office,
National Institute on Aging, National Institutes of Health, 7201
Wisconsin Avenue, Suite 2C-212, Bethesda, MD 20892, 301-402-7700,
rv23r@nih.gov
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
Dated: May 14, 2007.
Jennifer Spaeth
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-2490 Filed 5-18-07; 8:45 am]
BILLING CODE 4140-01-M